Contact this trialFirst, we need to learn more about you.
Nivolumab Maintenance for Central Nervous System Lymphoma
Recruiting1 awardPhase 2
Basking Ridge, New Jersey
This trial is testing if nivolumab, a drug that boosts the immune system, can prevent the return of a specific brain cancer in patients who still show signs of cancer after their first treatment. Nivolumab has shown promising activity in various cancers.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service